Schizophrenia researchHumansSchizophreniaMaleFemaleCross-Sectional Studies
Cannabis use and cardiometabolic risk in schizophrenia.
Jai Paris, Olivia Laurendi, Victoria Arnet, Cherrie Galletly
Published: 202610.1016/j.schres.2025.11.013
Abstract
PURPOSE: Metabolic syndrome (MetS) is common in schizophrenia and drives cardiovascular risk. While cannabis use and potency are increasing, the impact of cannabis on cardiometabolic health in schizophrenia remains unclear. This study assessed the as…
Preview only. Read the full abstract at the source